Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
Temperatures Breaking Records in U.S and Abroad
The heat wave continues to break records across the country with Phoenix recording 19 straight days of over 110 degrees as the southwestern cities are also coming close to records as well. Iran recorded a heat index of 152 degrees on Sunday with high temperatures affecting a big portion of the planet.
Fibroid Awareness Month Shines Light on Painful Condition
July is Fibroid Awareness Month, and it's an opportunity to raise awareness for uterine fibroids, a painful condition estimated to impact a staggering 26 million women nationwide. Cheddar's own Ashley Mastronardi spoke to one woman who shares her life-changing experience with fibroids.
Millions Feeling the Heat Around the World
High temperatures continue to affect people in the U.S. and abroad, including in Iran where it reached 152 degrees on Sunday. The southwestern part of the U.S. continues to experience extreme weather after over a week of a heat wave.
Load More